Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)
Summary
- Eligibility
- for people ages 18-99 (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedcompletion around
- Principal Investigator
- by Varun Monga, M.D
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Varun Monga, M.D
Dr. Varun Monga is a Board Certified Medical Oncologist who serves as an Clinical Associate Professor of Medicine in the Division of Hematology and Oncology. He joined UCSF Medical Center in 2023 and he provides patient care services limited to UCSF Sarcoma Center and Cancer Clinical Trials and Investigational Treatments Center.
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Polaris Group
- ID
- NCT05712694
- Phase
- Phase 3 research study
- Study Type
- Interventional
- Participants
- Expecting 300 study participants
- Last Updated